FindTrial
Sign In

Survey study to collect the side effects of suppression of menses amongst females caused by use of menstrual delaying pills

A CROSS-SECTIONAL SURVEY STUDY TO ASSESS THE SYMPTOMS ASSOCIATED WITH ARTAVA VEGADHARANA FOLLOWING THE USE OF MENSTRUAL DELAYING PILLS. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/08/072392
Enrollment
30
Registered
2024-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Sumatibhai Shah Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females who have taken menstrual delaying pills and the next cycle of menses is resumed.

Exclusion criteria

Exclusion criteria: Female subjects with chronic illness like hypertension, diabetes, thyroid diseases, arthritis, etc. Subjects taking any medications like blood thinners, sedatives, addictions or on psychiatric treatment, subjects with chronic gynaecological diseases or using hormonal contraceptives and subjects with BMI greater than 30.

Design outcomes

Primary

MeasureTime frame
It will help to collect the symptoms associated with artavavega dharana caused by use of menstrual delaying pillsTimepoint: From inclusion to 6 months—

Secondary

MeasureTime frame
It will help to find any association between duration of pill use and occurrence of symptoms related to artava vegadharana.Timepoint: From inclusion to 6 months—

Countries

India

Contacts

Public ContactDr Nitesh Joshi

MAMs Sumatibhai Shah Ayurved Mahavidyalaya

dr.niteshjoshi@rediffmail.com9890720745

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026